|
|||||
|
|
Pharmacokinetics of idarucizumab and its target dabigatran in patients requiring urgent reversal of the anticoagulant effect of dabigatran |
|
| Authors: | Stephan Glund Kelly Coble Dietmar Gansser Joachim Stangier Karin Hoermann Charles V. Pollack Paul Reilly |
| Abstract: | |
| Keywords: | anti‐drug antibodies dabigatran idarucizumab pharmacokinetics reversal agent |